Altor Bioscience Investors Fail To Halt $290M NantCell Merger
Altor Bioscience Corp. investors lost a bid Tuesday for a temporary restraining order blocking the closing of Altor's $290 million merger with billionaire physician Patrick Soon-Shiong's NantCell Inc., with the Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article